Colliers Securities analyst Steve Frankel maintained a Buy rating on Dolby Laboratories (NYSE:DLB) on Monday, setting a price target of $115, which is approximately 16.77% above the present share price of $98.48.
Frankel expects Dolby Laboratories to post earnings per share (EPS) of $0.54 for the third quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Strong Buy rating of shares in Dolby Laboratories, with an average price target of $119.33.
The analysts price targets range from a high of $128 to a low of $115.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $286.8 million and a net profit of $56.23 million. The company's market cap is $9.98 billion.
According to TipRanks.com, Colliers Securities analyst Steve Frankel is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 3.2% and a 49.41% success rate.
Dolby Laboratoties, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast, and entertainment industries. Its products include Cinema Imaging, Cinema Audio, Dolby Conference Phone, Dolby Voice Room, and Other Products. The company was founded by Ray Milton Dolby in 1965 and is headquartered in San Francisco, CA.